Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a common drug stop dangerous bleeding in pregnancy?

NCT ID NCT05840471

Disease control Sponsor: Hawler Medical University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether tranexamic acid, a drug that helps blood clot, can safely stop vaginal bleeding in pregnant women with abruptio placenta (when the placenta separates from the womb too early). 116 women at 24 weeks or more of pregnancy received either the drug or a placebo. Researchers tracked bleeding control, pregnancy length, and newborn health.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
tranexamic acid
What this could lead to
If successful, this could provide a safe way to reduce heavy bleeding in pregnant women with abruptio placenta, potentially improving outcomes for mothers and babies.
What could go wrong
This is a small, completed trial with 116 participants. The results may not apply to all women, and tranexamic acid carries risks like blood clots. More research is needed.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

116 people

The number who actually took part.

Started

Jan 2023

Finished

Feb 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 45 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * 24 weeks gestation and more * Stable hemodynamically * Accepted to participate Exclusion Criteria: * Hypersensitivity to tranexamic acid * Defective color vision * History of venous thromboembolism * Pre-existing medical conditions that could affect pregnancy outcomes (diabetes mellitus, hypertension, renal disease) * Smoker * Refused to participate in the trial

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Prolonged pregnancy are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Perinatal Death placental abruption Pregnancy, Prolonged Uterine Hemorrhage

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Prolonged pregnancy Vaginal bleeding

Contacts and locations

Locations

  • Shahla Kareem Alalaf

    Erbil, Kurdistan Region, 44001, Iraq

More trials for these conditions

Other studies related to the condition(s) this trial covers.